Eligible patients currently receiving or seeking chronic pain treatment at select clinics in Alberta will receive access to the Manage My Pain app as part of their treatment plan

March 27, 2023 (Edmonton, AB) – ManagingLife is proud to announce its collaboration with Alberta Health Services (AHS), with funding from the Ontario Bioscience Innovation Organization (OBIO®) through its Early Adopter Health Network (EAHN™), to support patients living with chronic pain across Edmonton and Calgary.

Manage My Pain, the app developed by ManagingLife, has been shown to improve the outcomes of people living with chronic pain and will be offered to patients referred to participating chronic pain clinics in both cities as part of an evaluation of the app.

Manage My Pain helps patients track their symptoms, learn self-management techniques, and communicate with their care team during clinical visits. With over 20% of Albertans living with chronic pain, this app aims to improve the quality of life and economic well-being of those affected.

A feasibility study last year yielded positive feedback from both patients and clinicians. As a result, AHS is further evaluating ManagingLife’s digital solution with a focus on health outcomes and health resource utilization.

With support from OBIO® through the EAHN™ program, AHS will evaluate Manage My Pain’s uptake and satisfaction by both patients and clinicians. Its impact will also be assessed on clinical outcomes and healthcare utilization.

Due to the high demand for the multidisciplinary chronic pain treatment clinics located in Calgary and Edmonton, patients often face long waiting times from their referral to their initial visit to a pain clinic. AHS sees digital innovation as a key component to supporting patients while they wait to be seen by the clinics as well as when they are being treated.

“OBIO® is excited to support this EAHN-funded evaluation between AHS and ManagingLife, because of the impact that innovation can have in addressing the treatment and management of chronic pain patients across Canada,“ said Dr. Maura Campbell, President and CEO of OBIO®. “This project is an example of how EAHN™ can facilitate adoption of innovative technologies across Canada to help Canadian companies establish markets domestically.”

ManagingLife’s solution, Manage My Pain, is clinically validated to improve the outcomes of people living with chronic pain. Manage My Pain allows patients to track and analyze their symptoms while providing educational content based on best practices in pain psychology about how pain works and strategies to help manage it. Reports created by the solution facilitate improved communication between patients and doctors to support treatment decisions.

About ManagingLife
ManagingLife is a privately held Corporation based in Toronto, Canada that has developed a digital solution for pain management that combines patient self-management, remote monitoring and analytics to help chronic pain sufferers and practitioners learn more about their condition and better communicate with each other. With its award-winning app, Manage My Pain, ManagingLife works with disability carriers, health plans, pain clinics, and clinical trials to help healthcare professionals better measure and manage their patients’ pain and medications. For more information, please visit managinglife.com or contact Nadia Bashir, Media Relations.

About OBIO®

Founded in 2009, OBIO®, a not-for-profit, membership-based organization dedicated to advancing health technology innovation and commercialization, is prioritizing the evaluation of new technologies through their Early Adopter Health Network (EAHN™) to provide solutions. OBIO® is engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies, positioning Canada as a leader in the international marketplace. For more information, please visit OBIO.ca or contact Bibaswan Ghoshal, Director, Market Acceleration, OBIO®.

Previous
Previous

Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform into Non-Ophthalmic Space

Next
Next

Bruyère Procures Innovative Patient Transfer Technology by Able Innovations